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A B S T R A C T
Understanding the molecular and cellular mechanisms involved during the onset of epilepsy is crucial for elu-
cidating the overall mechanism of epileptogenesis and therapeutic strategies. Previous studies, using a penty-
lenetetrazole (PTZ)-induced kindling mouse model, showed that astrocyte activation and an increase in peri-
neuronal nets (PNNs) and extracellular matrix (ECM) molecules occurred within the hippocampus. However, the
mechanisms of initiation and suppression of these changes, remain unclear.
Herein, we analyzed the attenuation of astrocyte activation caused by dizocilpine (MK-801) administration,
as well as the anticonvulsant effect of α-pinene on seizures and production of ECM molecules. Our results
showed that MK-801 significantly reduced kindling acquisition, while α-pinene treatment prevented an increase
in seizures incidences. Both MK-801 and α-pinene administration attenuated astrocyte activation by PTZ and
significantly attenuated the increase in ECM molecules.
Our results indicate that astrocyte activation and an increase in ECM may contribute to epileptogenesis and
suggest that MK-801 and α-pinene may prevent epileptic seizures by suppressing astrocyte activation and ECM
molecule production.
1. Introduction
Epilepsy is a neurological disorder that manifests with rapid, re-
current seizures resulting from the synchronized discharging of brain
neurons. At least 1 % of the world’s population is affected by epilepsy
(Fisher et al., 2005; WHO Factsheet, 2001). Despite treatment with
currently available antiepileptic drugs (AEDs), 30 % of patients with
epilepsy remain refractory to therapy (Schmidt and Löscher, 2005;
Rahmati et al., 2013). Given the high proportion of patients who do not
respond to the currently available treatments, identifying seizure me-
chanisms and searching for new therapeutic targets is essential. How-
ever, the pathophysiological processes leading to epilepsy remain
poorly understood.
Kindling is a common functional model of temporal lobe epilepsy
(Kandratavicius et al., 2014), and it references an initially small epi-
leptic stimuli being repeated and amplified, much like the initial
kindling of twigs to produce a large fire. Systemic administration of PTZ
establishes systemic, tonic-clonic seizures and provides an excellent
model for studying epileptogenesis in mice (Mandhane et al., 2007).
PTZ-induced kindling is the most common animal model for studying
seizure mechanisms and understanding the neurobiology of epilepsy. It
has also been used for the examination of learning and memory pro-
blems caused by seizures and evaluation of new treatment effects.
(Dhir, 2012; Pahuja et al., 2013; Atinga et al., 2015).
Despite treatment with AEDs, epilepsy remains challenging due to
the side effects from these medications (Elger et al., 2004). Recent re-
search has focused on the development of more effective AEDs with
minimal or no side effects. Many monoterpenes, commonly present in
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essential oils, are known for their anticonvulsant properties (de Sousa
et al., 2006; Zhu et al., 2014; Souto-Maior et al., 2017). The mono-
terpene, α-pinene, is an organic terpene compound found in coniferous
oils, and is the primary monoterpene of pine trees (Simonsen and Ross,
1957). Essential oils, including α-pinene, have been used to treat var-
ious diseases (Mercier et al., 2009). α-pinene is widely used as a food
flavoring ingredient (Pereira Limberger et al., 2007; Ana Cristina da
Silva Rivas et al., 2012) and has been approved as a safe food additive
by the U.S. Food and Drug Administration (FDA 2015). α-pinene has
anti-inflammatory (Martin et al., 1993; Zhou et al., 2004), anti-de-
pressive (Ahmad et al., 2013), anti-oxidative (Singh et al., 2006), anti-
tumor (Eftekhar et al., 2004), and anti-nociceptive effects (Him et al.,
2008). However, the antiepileptic effects of α-pinene remain unclear.
We investigated the protective effects of α-pinene on status epilepticus
in an experimental model of epilepsy and explored the potential mo-
lecular events involved in this effect.
The molecular mechanisms underlying kindling and the develop-
ment of abnormal excitability in epilepsy are poorly understood.
Studies have shown that changes in synaptic plasticity lead to epilepsy
(Scharfman et al., 2002; Jarero-Basulto JJ et al., 2018). We have shown
in previous studies that activation of astrocytes in the PTZ-induced
kindling model may lead to increased ECM secretion (Ueno et al.,
2019a, 2019b). Dizocilpine (MK-801), a noncompetitive N-methyl-D-
aspartate (NMDA) antagonist, has been reported to significantly reduce
glutamate-stimulated astrocyte activation (Chan et al., 1990). Since
cultured astrocytes lack NMDA receptors, it is suggested that MK-801
suppressed astrocyte activation by a mechanism independent of the
NMDA receptor. To elucidate the mechanism of ECM increase and as-
trocyte activation in kindling acquisition, we previously administered
MK-801 and investigated the effects within a PTZ-induced kindling
model.
ECM in the central nervous system (CNS) includes components such
as hyaluronic acid, tenascin-R, glycoproteins, and chondroitin sulfate
proteoglycans (CSPG) (Maeda, 2015). In the mature CNS, ECM mole-
cules are distributed as neural granules or perineuronal nets (PNNs),
which are concentrated meshwork structures (Maeda, 2015). In the
cortex and hippocampus, PNNs mainly form around parvalbumin-po-
sitive GABAergic interneurons (Slaker et al., 2016). Although the exact
function of PNNs is unknown, it is believed that they stabilize synaptic
connectivity and regulate retention of synaptic plasticity (Frischknecht
et al., 2009; Kalb and Hockfield, 1994; Pizzorusso et al., 2002). Some
reports have suggested that plasticity is controlled by the aggrecan
molecule, which is a component of PNNs (McRae et al., 2007; Ye and
Miao, 2013; Ueno et al., 2017a, 2017b). The plant lectin, wisteria
floribunda agglutinin (WFA), is commonly used to detect PNNs. WFA
binds to N-acetylgalactosamine (Seeger et al., 1994; Schweizer et al.,
1993; Brückner et al., 1993). The antibody Cat-315, which is specific
for the aggrecan molecule, is also often used to detect PNNs. Cat-315
recognizes the human natural killer 1 carbohydrate epitope of aggrecan
(Matthews et al., 2002; McRae et al., 2007; Dino et al., 2006). In this
study, WFA lectin and Cat-315 were used to investigate the expression
of PNNs and other ECM molecules.
We considered that α-pinene, which has been reported to have
anticonvulsant activity, may also exhibit antiepileptic activity. We also
speculated that MK-801, which suppresses astrocyte activation, may
exhibit antiepileptic activity. This study aimed to investigate whether
α-pinene and MK-801 had antiepileptic effects and could inhibit status
epilepticus. Furthermore, we sought to clarify the effects of α-pinene
and MK-801 on astrocyte activation and ECM molecule expression
during kindling acquisition.　The findings may lead to the develop-
ment of new therapeutic agents to prevent epilepsy.
2. Methods
2.1. Animals
Eleven-week-old, male mice (C57BL/6 N) were used for all experi-
ments. Mice were housed, five to a cage, under standard animal care
conditions. All procedures related to animal maintenance and experi-
mentation were approved by the Committee for Animal Experiments at
the Kawasaki Medical School Advanced Research Center and con-
formed to the U.S. National Institutes of Health Guide for the Care and
Use of Laboratory Animals (NIH Publication No. 80-23, revised in
1996). Mice were purchased from Charles River Laboratories
(Kanagawa, Japan) and were housed in cages and provided nesting
material, with food and water provided ad libitum, under light/dark
conditions (lights on at 7:00 A.M., lights off at 9:00 P.M.) and tem-
perature maintained at 23 °C – 26 °C.
2.2. Drugs
PTZ (Sigma-Aldrich Japan, Tokyo, Japan) was dissolved in saline at
20 mg/mL. (+)-MK-801 (dizocilpine hydrogen maleate; 130–17381,
FUJIFILM Wako Pure Chemical Corporation, Osaka, Japan) was diluted
in saline (0.1 mg/mL) and administered i.p. in a volume of 0.2 mg/kg.
This dose was selected based on a previous study at 0.2 mg/kg in mice
(Gray et al., 2009; Bygrave et al., 2016). α-pinene was acquired from
FUJIFILM Wako Pure Chemical Corporation (169–21242). α-pinene
was diluted in saline containing 5 % Tween-80 at a concentration of 20
mg/mL and administered i.p. in a volume of 20 mg/kg. This dose was
selected based on previous studies (Yang et al., 2016).
2.3. Pentylenetetrazole-induced kindling procedure
All mice were randomized into four groups (n 15, per group). A dose
of 40 mg/kg was injected i.p. once a day for a total period of 15 days.
Vehicle control mice were injected with saline. Seizure events during a
30 min period, following each PTZ injection, were observed. The re-
sultant seizures were scored as follows (Watanabe et al., 2011): Stage 0
(no response); stage 1 (ear and facial twitching); stage 2 (myoclonic
body jerks); stage 3 (forelimb clonus, rearing); stage 4 (clonic convul-
sions, turn onto the side); stage 5 (generalized clonic convulsions, turn
onto the back). To determine the effects of MK-801 and α-pinene on the
PTZ-induced kindling progress, mice received either PTZ administra-
tion alone, or were pretreated with either MK-801, or α-pinene, 30 min
prior to each PTZ injection. Treatments were administered once daily
for a total of 15 injections. Duration of treatment was chosen based on
our previous study and that of others (Li et al., 2014; Sun et al., 2019;
Ueno et al., 2019a, 2019b). On the 16th day, mice were sacrificed, and
their brains were removed.
2.4. Tissue preparation
Mice were anesthetized with a lethal dose of sodium pentobarbital
(120 mg/kg, i.p.) and transcardially perfused with 25 mL of phosphate-
buffered saline (PBS) followed by 100 mL of 4 % paraformaldehyde in
PBS (pH 7.4). Brains were dissected and post-fixed overnight at 4 °C in
the above fixative. The brains were then cryoprotected in 15 % sucrose
for 12 h followed by 30 % sucrose for 20 h at 4 °C. Next, the brains were
frozen in an optimum cutting temperature compound (Tissue-Tek;
Sakura Finetek, Tokyo, Japan) using a slurry of normal hexane in dry
ice. Serial coronal sections with a thickness of 40 μm were obtained at
−20 °C using a cryostat (CM3050S; Leica Wetzlar, Germany). The
sections were collected in ice-cold PBS containing 0.05 % sodium azide.
2.5. Immunohistochemistry
We treated the cryostat sections with 0.1 % Triton X-100 with PBS
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at room temperature for 15 min. After three washes with PBS, we in-
cubated the sections with 10 % normal goat serum (ImmunoBioScience
Corp., Mukilteo, WA) in PBS at room temperature for 1 h. Sections were
then washed three times with PBS, and incubated overnight at 4 °C in
PBS containing biotinylated WFA (B-1355, Vector Laboratories; 1:200)
and/or the antibodies described in the subsection “Antibodies and
lectins.” After washing with PBS, we incubated the sections with Alexa
Fluor 594-conjugated streptavidin (S11227; Molecular Probes, Eugene,
OR) and/or the corresponding secondary antibodies (described in the
subsection “Antibodies and lectins”) at room temperature for 2 h. We
rinsed the labeled sections again with PBS and mounted them on glass
slides with Vectashield medium (H-1400; Vector Laboratories,
Funakoshi Co., Tokyo, Japan). We stored the prepared slides at 4 °C
until microscopy analysis was performed.
2.6. Antibodies and lectins
We used the following lectins and primary antibodies for staining:
biotinylated WFA (B-1355, Vector Laboratories; 1:200), mouse anti-
parvalbumin (PV; clone PARV-19, P3088; Sigma-Aldrich Japan, Tokyo,
Japan; 1:1000), mouse anti-NeuN (clone A60, MAB377; Millipore;
1:500), mouse anti-aggrecan (Cat-315; MAB1581, MERCK; 1:1000),
rabbit anti-glial fibrillary acidic protein (GFAP; ab7260; Abcam,
Cambridge, MA; 1:1000), rabbit anti-ionized calcium-binding adapter
molecule 1 (Iba-1; 019–19741; FUJIFILM Wako Pure Chemical
Corporation, Osaka, Japan; 1:1000), mouse anti-glutamic acid dec-
arboxylase 67 (GAD67; clone 1 G10.2, MAB5406; Millipore, Bedford,
MA; 1:1000), and guinea pig anti-vesicular glutamate transporter 1
(VGLUT1; AB5905; Millipore; 1:1000).
We used the following secondary antibodies for visualization: Alexa
Fluor 488-conjugated goat anti-mouse IgG (ab150113; Abcam,
Cambridge, MA; 1:1000), Alexa Fluor 594-conjugated goat anti-guinea
pig (A-11076; Thermo Fisher Scientific, Waltham, MA; 1:500), FITC-
conjugated anti-mouse IgM (sc-2082, Santa Cruz Biotechnology, Santa
Cruz, CA, 1:1000), Texas Red-conjugated goat anti-rabbit (TI-1000;
Vector Laboratories, Funakoshi Co., Tokyo, Japan), and streptavidin-
conjugated Alexa Fluor 594 (S11227, Thermo Fisher Scientific; 1:1000).
2.7. Microscopy imaging
For quantification of the density of PV-, WFA-, and Cat-315-positive
PNNs and analysis of ECM fluorescence intensities, we used confocal
laser scanning microscopy (LSM700; Carl Zeiss, Oberkochen, Germany)
to obtain images of stained sections. Images (1024 × 1024 pixels) were
saved as TIFF files using ZEN software (Carl Zeiss). Briefly, we per-
formed our analysis using a 10× objective lens and a pinhole setting
that corresponded to a focal plane thickness of less than 1 μm. For
observing ECM molecules, GAD67- and VGLUT1-positive synaptic
terminals, samples were randomly selected and high-magnification
images using a 100× objective lens were acquired. Prior to capture, the
exposure time, gain, and offset were carefully set to ensure a strong
signal, but to avoid saturation. Identical capture conditions were used
for all sections. Images from whole sections were acquired using a 10×
objective lens of a fluorescence microscope (BZ-X; KEYENCE, Tokyo,
Japan) and we merged them using the KEYENCE BZ-X Analyzer soft-
ware (KEYENCE).
2.8. Quantification of labeled PNNs and ECM
Brain regions were identified in accordance with the mouse brain
atlas of Franklin and Paxinos (2012). From each mouse, four serial,
coronal hippocampal sections were selected and processed for staining.
All confocal images were acquired as TIFF files, and analyzed with the
NIH ImageJ software (NIH, Bethesda, MD; http://rsb.info.nih.gov/nih-
image/). Stained PNNs (soma size above 60 μm2) were manually tagged
and counted within the area of interest. Background intensities were
subtracted using unstained portions (region of the nucleolus) of each
section. Labeled neuron density was calculated as cells/mm2. Quanti-
fications were performed by a blinded, independent observer. For
quantifying the fluorescence intensity of ECM-positive molecules,
GAD67- and VGLUT1-positive synaptic terminals, WFA-, and Cat-315-
positive PNNs, we selected four sections from each mouse brain and
stained as described above. The ellipses circumscribing the WFA-, and
Cat-315-positive PNNs were traced manually on 8-bit images of each
section, and the gray levels for WFA or Cat-315 labeling were measured
using the ImageJ software, which was assigned arbitrary units (a.u.).
We manually outlined the parts excluding PNNs and measured the gray
level with NIH ImageJ. Background intensities were subtracted using
unstained portions of each section. We acquired all confocal images as
TIFF files and analyzed them with NIH ImageJ. We coded the slides and
a blinded, independent observer quantified them.
2.9. Data analysis
Data are expressed as box plots of five animals per group. Statistical
significance, set at p<0.05, was determined by two-way analysis of
variance followed by Bonferroni t-tests.
3. Results
3.1. Effect of MK-801 and α-pinene in the pentylenetetrazole-induced
kindling mouse model
Repeated administration of PTZ (40 mg/kg) over a period of 15 days
resulted in a steady increase in seizure scores, effectively inducing
kindling in mice (Fig. 1A). Administration of MK-801 prior to each PTZ
injection, decreased seizure severity. In addition, pretreatment with α-
pinene, prior to each PTZ injection, was found to suppress the increase
in seizure score in comparison with the PTZ only group (Fig. 1A).
Pretreatment with MK-801, or α-pinene, also significantly changed the
maximal seizure score distribution on the 15th day (Fig. 1B). Further-
more, the lethality rate following the PTZ injections, decreased sig-
nificantly in response to pretreatment with α-pinene (Fig. 1C). 0 %
lethality rate was observed in PTZ-kindled, MK-801-treated mice
(Fig. 1C).
3.2. Effect of MK-801 and α-pinene on PV-positive neurons, WFA-positive
and Cat-315-positive PNNs in the PTZ-kindled mouse hippocampus
PV-positive mouse hippocampal neurons were observed and com-
pared among experimental groups (Fig. 2A-D and 3 A). To examine the
spatial distribution of PNNs and ECM molecules, we stained for WFA
(Fig. 2E-H, 3 A), and Cat-315 (Fig. 2I-L, 3 A). The distribution of PV-
positive neurons, and WFA-positive/Cat-315-positive PNNs in the hip-
pocampus was very similar in all groups.
We quantified PV-positive neurons, and WFA-positive and Cat-315-
positive PNNs in the hippocampi of different treatment groups (Fig. 3B-
D, Table 1A-C). In the CA1 hippocampal region, the density of PV-po-
sitive neurons was significantly lower in α-pinene treated, PTZ-induced
mice than in control mice (Fig. 3B, Table 1A). In the CA3 region, both
MK-801 and α-pinene pretreatments, significantly attenuated the in-
creased density of PV-positive neurons induced by PTZ administration
(Fig. 3B, Table 1A). In the CA1 region, the density of WFA-positive
PNNs was significantly lower in MK-801 treated, PTZ-induced mice
than in PTZ-kindled mice (Fig. 3C, Table 1B). In the CA3 region, both
MK-801 and α-pinene pretreatments, significantly attenuated the in-
creased density of WFA-positive PNNs induced by PTZ administration
(Fig. 3C, Table 1B). In the CA3 region, the density of Cat-315-positive
PNNs, in both MK-801 treated, PTZ-induced and α-pinene treated, PTZ-
induced mice, was significantly lower than in PTZ-kindled mice
(Fig. 3D, Table 1C). In other regions, there was no significant difference
in the density of Cat-315-positive PNNs between the four groups
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(Fig. 3D, Table 1C).
To examine whether PNNs are associated with PV-positive neurons
in the mouse hippocampi of different experimental groups, we con-
ducted a quantitative analysis (Fig. 3E-H, Table 1D-G). In the CA1 re-
gion, the percentage of PV-positive neurons, not surrounded by both
WFA-positive and Cat-315-positive PNNs, in the PTZ-kindled mice was
significantly lower than in both control mice and α-pinene treated, PTZ-
induced mice (Fig. 3E, Table 1D). In the CA3 area, the percentage of
PV-positive neurons, not surrounded by both WFA-positive and Cat-
315-positive PNNs, in the PTZ-kindled mice, was significantly lower
than in control mice (Fig. 3E, Table 1D). In the dentate gyrus (DG) area,
the percentage of PV-positive neurons, surrounded by both WFA- and
Cat-315-positive PNNs, in MK-801 treated, PTZ-induced mice was sig-
nificantly lower than in α-pinene treated, PTZ-induced mice (Fig. 3F,
Table 1E). In the CA1 region, the percentage of PV-positive neurons,
surrounded by WFA-positive PNNs in the PTZ-kindled mice, was sig-
nificantly higher than in both control mice and α-pinene treated, PTZ-
induced mice (Fig. 3G, Table 1F). In the DG area, the percentage of PV-
positive neurons, surrounded by WFA-positive PNNs, in α-pinene
treated, PTZ-induced mice, was significantly higher than in MK-801
treated, PTZ-induced mice (Fig. 3G, Table 1F). There were no sig-
nificant differences in the percentage of PV-positive neurons, sur-
rounded by Cat-315-positive PNNs, between the four experimental
groups in most of the areas that we examined (Fig. 3H, Table 1G).
3.3. Effect of MK-801 and α-pinene on PV-positive, WFA-positive, and Cat-
315-positive fluorescence intensity in the PTZ-kindled mouse hippocampus
To analyze the effect of PTZ-kindling on the expression of PV pro-
tein, we analyzed the fluorescence intensity of PV-positive neurons in
the hippocampi of different experimental groups (Fig. 4A, Table 1H). In
both the CA1 and CA3 areas of the hippocampus, both MK-801 and α-
pinene pretreatments significantly attenuated the increased PV fluor-
escence intensity induced by PTZ administration (Fig. 4A, Table 1H). In
the DG area, PV fluorescence intensity was lower in MK-801 treated,
PTZ-induced mice than in the other three groups (Fig. 4A, Table 1H).
To analyze the effect of MK-801 and α-pinene on the expression of
WFA-positive, and Cat-315-positive molecules in the PTZ-kindled
mouse hippocampus, we analyzed the fluorescence intensity of each
WFA-positive PNN, and Cat-315-positive PNN, in different treatment
groups (Fig. 4B, C, Table 1I, J). In the CA1 area, WFA fluorescence
intensity was lower in α-pinene treated, PTZ-induced mice than in the
other three groups (Fig. 4B, Table 1I). In the CA3 area, MK-801 pre-
treatment significantly attenuated the increased WFA fluorescence in-
tensity induced by PTZ administration (Fig. 4B, Table 1I). In the CA1
area, Cat-315 fluorescence intensity was lower in α-pinene treated,
PTZ-induced mice than in both PTZ-kindled mice and MK-801 treated,
PTZ-induced mice (Fig. 4C, Table 1J). In the CA3 area, Cat-315 fluor-
escence intensity was lower in MK-801 treated, PTZ-induced mice than
in PTZ-kindled mice (Fig. 4C, Table 1J). In the DG area, Cat-315
fluorescence intensity was lower in MK-801 treated, PTZ-induced mice
than in control mice (Fig. 4C, Table 1J).
Next, we analyzed WFA-positive and Cat-315-positive molecules,
excluding PNNs, in each experimental group (Fig. 4D, E, Table 1K, L).
In the CA1 area, the mean fluorescence intensity of WFA-positive mo-
lecules, excluding PNNs, was lower in α-pinene treated, PTZ-induced
mice than in the other three groups (Fig. 4D, Table 1K). In the CA3
area, the mean fluorescence intensity of WFA-positive molecules, ex-
cluding PNNs, was lower in control mice than in the other three groups
(Fig. 4D, Table 1K). In the CA1 area, the mean fluorescence intensity of
Cat-315-positive molecules, excluding PNNs, in both MK-801 treated,
PTZ-induced and α-pinene treated, PTZ-induced mice was significantly
lower than in PTZ-kindled mice (Fig. 4E, Table 1L). In the CA3 area, the
mean fluorescence intensity of Cat-315-positive molecules, excluding
PNNs, in both MK-801 treated, PTZ-induced and α-pinene treated, PTZ-
induced mice were significantly lower than in PTZ-kindled mice
(Fig. 4E, Table 1L).
3.4. Effect of MK-801 and α-pinene on GFAP-positive astrocytes and Iba-1-
positive microglia in the PTZ-kindled mouse hippocampus
To analyze the effects of MK-801 and α-pinene on astrocytosis in-
duced by PTZ-kindling, we analyzed GFAP-positive astrocytes in the
CA1 hippocampal region of different treatment groups (Fig. 5A-D).
GFAP-positive astrocytes appeared ramified, forming more spreading
branches in the CA1 of PTZ-kindled, MK-801 treated, PTZ-induced, and
α-pinene treated, PTZ-induced mice compared with controls. We
quantified the GFAP-positive areas of the CA1 in different treatment
groups (Fig. 5I, Table 1M). In the SO area of the CA1 region, we found
that the GFAP-positive area in MK-801 treated, PTZ-induced mice was
lower than in the PTZ-kindled mice. In the SR area of the CA1 region,
the GFAP-positive areas in both MK-801 treated, PTZ-induced and α-
pinene treated, PTZ-induced mice were significantly lower than in PTZ-
kindled mice.
To examine the effects of MK-801 and α-pinene on immune acti-
vation induced by PTZ-kindling, the morphology of Iba-1-positive mi-
croglia in the CA1 was examined (Fig. 5E-H). In the CA1 area, there was
no significant difference in the morphology of Iba-1-positive microglia
between our four experimental groups.
Fig. 1. Effect of MK-801 and a-pinene on PTZ-induced kindling.
(A) Graphs showing the seizure score as assessed on the 1st, 3rd, 5th, 7th, 9th,
11th, 13th, and 15th day of the study. Data are expressed as the mean± SEM.
*p< 0.05 versus saline-treated mice. The p-values were calculated using the
repeated measures ANOVA in A. (B) Distribution of mice by maximal seizure
score on the 15th day of the study. (C) Percent lethality in different treated
groups.
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3.5. Effects of MK-801 and α-pinene on glutamatergic and GABAergic
synaptic terminals in the PTZ-kindled mouse hippocampus
To examine the effects of MK-801 and α-pinene on the alteration of
synaptic terminals induced by PTZ-kindling, we labeled both VGLUT1-
positive synaptic terminals and GAD67-positive synaptic terminals
(Fig. 6A-H). VGLUT1- and GAD67-positive synaptic terminals were
expressed in the neuropil of the mouse hippocampi (Fig. 6A-H). We
quantified area-specific VGLUT1- and GAD67-positive signal in-
tensities, excluding GAD67-positive neurons, in the CA1 areas (Fig. 6I,
J, Table 1N, O).
In the SO area of the CA1 region, VGLUT1 fluorescence intensity in
MK-801 treated, PTZ-induced mice was significantly lower than in both
PTZ-kindled and α-pinene treated PTZ-induced mice (Fig. 6I,
Table 1N). In the SR area of the CA1 region, VGLUT1 fluorescence in-
tensity in α-pinene treated, PTZ-induced mice was significantly higher
Fig. 2. PV, WFA, Cat-315, GFAP, Iba-1, VGLUT1, and GAD67-positive images in different treated group mouse hippocampus.
Representative images of PV-positive neurons (A–D), WFA-positive molecules (E–H), Cat-315-positive molecules (I–L), GFAP-positive cells (M–P), Iba-1-positive
microglia (Q–T), VGLUT1-positive puncta (U–X), and GAD67-positive puncta (Y-b) in the mouse hippocampus of control (A, E, I, M, Q, U, Y), PTZ-kindled (B, F, J, N,
R, V, Z), PTZ-kindled MK-801-treated (C, G, K, O, S, W, a), and PTZ-kindled a-pinene treated mice (D, H, L, P, T, X, b). Scale bars: 500 μm in b (applies to A–Z, a–b).
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Fig. 3. The densities of PV-positive neurons, WFA-positive, and Cat-315-positive PNNs in different treated group mouse hippocampus.
Representative triple immunofluorescent images of PV-positive neurons, WFA-positive PNNs, and Cat-315-positive PNNs in the CA3 of control, PTZ-kindled, PTZ-
kindled MK-801-treated, and PTZ-kindled α-pinene treated mice (A). The arrows indicate PV-positive neurons co-localized with PNN markers. The arrowheads
indicate PV-positive neurons not co-localized with PNN markers. Region-specific patterns of PV-positive neuron density (B), WFA-positive PNN density (C), and Cat-
315-positive PNN density (D) are shown. The percentage of PV-positive neurons that do not contain both WFA- and Cat-315-positive PNNs (E), the percentage of PV-
positive neurons that contain both WFA- and Cat-315-positive PNNs (F), the percentage of PV-positive neurons that contain WFA-positive PNNs (G), and the
percentage of PV-positive neurons that contain Cat-315-positive PNNs (H) in the hippocampus are shown. Data are presented as the mean±SEM (n = 6 mice per
group). The p values indicate two-way ANOVA by Bonferroni t-test. *p< 0.05 for comparison between different treated groups in the same region. Respective p
values are listed in Table 1. Scale bars: 100 μm in A.
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Table 1
P values for Figs. 3–6.
A. Fig. 3B B. Fig. 3C C. Fig. 3D
PV neurons WFA-positive PNNs Cat-315-positive PNNs
CA1 control vs PTZ 0.778 0.105 0.249
control vs PTZ + MK801 0.073 0.67 0.703
control vs PTZ + α-pinene 0.022 0.882 0.306
PTZ vs PTZ + MK801 0.225 0.043 0.385
PTZ vs PTZ + α-pinene 0.101 0.076 0.752
PTZ + MK801 vs PTZ + α-pinene 0.585 0.775 0.498
CA3 control vs PTZ 0.042 0.004 < 0.001
control vs PTZ + MK801 0.591 0.875 0.297
control vs PTZ + α-pinene 0.279 0.4368 0.679
PTZ vs PTZ + MK801 0.013 0.004 < 0.001
PTZ vs PTZ + α-pinene 0.003 0.022 < 0.001
PTZ + MK801 vs PTZ + α-pinene 0.564 0.515 0.519
DG control vs PTZ 0.706 0.626 0.771
control vs PTZ + MK801 0.947 0.722 0.84
control vs PTZ + α-pinene 0.602 0.202 0.416
PTZ vs PTZ + MK801 0.655 0.418 0.634
PTZ vs PTZ + α-pinene 0.402 0.538 0.68
PTZ + MK801 vs PTZ + α-pinene 0.634 0.09 0.29
D. Fig. 3E E. Fig. 3F F. Fig. 3G G. Fig. 3H
WFA− Cat-315− PNNs / PV
neurons
WFA+ Cat-315+ PNNs / PV
neurons
WFA+ PNNs / PV
neurons
Cat-315+ PNNs / PV neurons
CA1 control vs PTZ 0.03 0.446 0.047 0.438
control vs PTZ + MK801 0.531 0.463 0.624 0.349
control vs PTZ + α-pinene 0.658 0.899 0.675 0.927
PTZ vs PTZ + MK801 0.087 0.865 0.121 0.988
PTZ vs PTZ + α-pinene 0.01 0.502 0.022 0.474
PTZ + MK801 vs PTZ + α-pinene 0.268 0.532 0.346 0.384
CA3 control vs PTZ 0.04 0.385 0.349 0.078
control vs PTZ + MK801 0.073 0.482 0.576 0.132
control vs PTZ + α-pinene 0.53 0.412 0.388 0.351
PTZ vs PTZ + MK801 0.573 0.774 0.63 0.609
PTZ vs PTZ + α-pinene 0.12 0.862 0.836 0.321
PTZ + MK801 vs PTZ + α-pinene 0.232 0.894 0.745 0.56
DG control vs PTZ 0.841 0.844 0.955 0.279
control vs PTZ + MK801 0.521 0.305 0.739 0.209
control vs PTZ + α-pinene 0.247 0.08 0.054 0.389
PTZ vs PTZ + MK801 0.725 0.274 0.737 0.95
PTZ vs PTZ + α-pinene 0.225 0.185 0.117 0.068
PTZ + MK801 vs PTZ + α-pinene 0.062 0.004 0.019 0.029
H. Fig. 4A I. Fig. 4B J. Fig. 4C
PV fluorescence WFA fluorescence Cat-315 fluorescence
CA1 control vs PTZ < 0.001 0.261 0.014
control vs PTZ + MK801 0.081 0.5 0.168
control vs PTZ + α-pinene < 0.001 0.001 0.441
PTZ vs PTZ + MK801 < 0.001 0.591 0.202
PTZ vs PTZ + α-pinene < 0.001 < 0.001 0.002
PTZ + MK801 vs PTZ + α-pinene 0.034 < 0.001 0.035
CA3 control vs PTZ < 0.001 < 0.001 < 0.001
control vs PTZ + MK801 0.031 0.349 0.316
control vs PTZ + α-pinene 0.342 0.041 0.025
PTZ vs PTZ + MK801 < 0.001 0.005 0.004
PTZ vs PTZ + α-pinene < 0.001 0.064 0.098
PTZ + MK801 vs PTZ + α-pinene 0.001 0.281 0.203
DG control vs PTZ 0.566 0.712 0.264
control vs PTZ + MK801 < 0.001 0.887 0.001
control vs PTZ + α-pinene 0.821 0.372 0.125
PTZ vs PTZ + MK801 < 0.001 0.78 0.22
PTZ vs PTZ + α-pinene 0.684 0.739 0.959
PTZ + MK801 vs PTZ + α-pinene < 0.001 0.387 0.128
K. Fig. 4D L. Fig. 4E
WFA fluorescence Cat-315 fluorescence
CA1: so control vs PTZ 0.193 < 0.001
control vs PTZ + MK801 0.567 < 0.001
control vs PTZ + α-pinene < 0.001 < 0.001
PTZ vs PTZ + MK801 0.404 < 0.001
PTZ vs PTZ + α-pinene 0.003 < 0.001
PTZ + MK801 vs PTZ + α-pinene < 0.001 0.339
CA1: sr control vs PTZ 0.844 < 0.001
(continued on next page)
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Table 1 (continued)
K. Fig. 4D L. Fig. 4E
WFA fluorescence Cat-315 fluorescence
control vs PTZ + MK801 0.58 < 0.001
control vs PTZ + α-pinene 0.107 < 0.001
PTZ vs PTZ + MK801 0.495 < 0.001
PTZ vs PTZ + α-pinene 0.109 < 0.001
PTZ + MK801 vs PTZ + α-pinene 0.276 0.536
CA3: so control vs PTZ < 0.001 < 0.001
control vs PTZ + MK801 < 0.001 0.089
control vs PTZ + α-pinene < 0.001 0.829
PTZ vs PTZ + MK801 0.167 < 0.001
PTZ vs PTZ + α-pinene 0.155 < 0.001
PTZ + MK801 vs PTZ + α-pinene 0.946 0.048
CA3: sr control vs PTZ 0.021 < 0.001
control vs PTZ + MK801 0.005 < 0.001
control vs PTZ + α-pinene < 0.001 0.05
PTZ vs PTZ + MK801 0.955 < 0.001
PTZ vs PTZ + α-pinene 0.539 < 0.001
PTZ + MK801 vs PTZ + α-pinene 0.503 0.074
M. Fig. 5I N. Fig. 6I O. Fig. 6J
% GFAP+ area VGLUT1 fluorescence GAD67 fluorescence
CA1: so control vs PTZ < 0.001 < 0.001 0.003
control vs PTZ + MK801 0.006 0.007 0.949
control vs PTZ + α-pinene < 0.001 < 0.001 < 0.001
PTZ vs PTZ + MK801 0.023 < 0.001 0.002
PTZ vs PTZ + α-pinene 0.145 0.673 < 0.001
PTZ + MK801 vs PTZ + α-pinene 0.404 < 0.001 < 0.001
CA1: sr control vs PTZ < 0.001 < 0.001 0.001
control vs PTZ + MK801 < 0.001 < 0.001 < 0.001
control vs PTZ + α-pinene < 0.001 < 0.001 < 0.001
PTZ vs PTZ + MK801 0.004 0.793 < 0.001
PTZ vs PTZ + α-pinene 0.052 0.011 < 0.001
PTZ + MK801 vs PTZ + α-pinene 0.333 0.005 < 0.001
*Significant difference compared with control mice in the same region (p< 0.05).
Fig. 4. Quantitative analyses of extracellular matrix molecules in the different treated group mouse hippocampus.
Quantified mean fluorescence intensity of PV-positive neurons (A), WFA-positive PNNs (B), Cat-315-positive PNNs (C), in the mouse hippocampus. Quantified mean
fluorescence intensity of WFA-positive molecules (D), and Cat-315-positive molecules (E), excluding the PNN, in the mouse hippocampus. Data are presented as the
mean± SEM (n = 6 mice per group). The p values indicate two-way ANOVA by Bonferroni t-test. *p<0.05 for comparison between different treated groups in the
same region. Respective p values are listed in Table 1.
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than in both PTZ-kindled and MK-801 treated, PTZ-induced mice.
In both the SO and SR areas of the CA1 region, GAD67 fluorescence
intensity in both MK-801 treated, PTZ-induced and α-pinene treated,
PTZ-induced mice was significantly lower than in PTZ-kindled mice
(Fig. 6J, Table 1O).
4. Discussion
In this study, we showed that MK-801 and α-pinene inhibit PTZ-
induced kindling acquisition. Furthermore, our results show that MK-
801 and α-pinene influence the activation of astrocytes as well as the
increase of ECM expression induced by PTZ. This result provides a new
insight into epilepsy development and may influence the development
of new therapeutic agents for epilepsy treatment.
In the PTZ provocation test, prior administration of MK-801 sig-
nificantly suppressed status epilepticus and exerted an antiepileptic
effect. Repeated administration of PTZ-induced severe seizures and
high mortality (Ammon-Treiber et al., 2007; Hussein et al., 2019). MK-
801 effectively reduced seizure severity and reduced mortality in PTZ
kindling mice. Several studies have shown that NMDA receptor an-
tagonists delay kindling acquisition and prevent the onset of seizures
(Dingledine et al., 1990).
In this study, α-pinene suppressed kindling acquisition by pre-
venting an increase in seizures by PTZ. However, during the first few
administrations of PTZ, α-pinene pre-administration did not appear to
attenuate seizures. In fact, it has been shown that α-pinene differs from
β-pinene in action and has no anticonvulsant action (Felipe et al.,
2019). Although the results of this study are consistent with previous
studies, we report the novel kindling inhibitory effect of α-pinene. As
with MK-801, increasing the dose of α-pinene may eliminate mortality.
Further studies are warranted to verify the action of α-pinene.
In the present study, the kindling model showed activation of as-
trocytes but not microglia. In PTZ provocation tests, prior administra-
tion of MK-801 significantly suppressed astrocyte activation in the
hippocampus. Reactive astrocytes are observed in the hippocampus of
epilepsy animal models (Borges et al., 2003; Shapiro et al., 2008), and
in the human hippocampus with temporal lobe epilepsy (Cohen-Gadol
et al., 2004). PTZ administration increases glutamate secretion in the
brain (Cremer et al., 2009). Glutamate induces astrocyte activation (as
measured by morphological changes and GFAP expression) in neuronal
/ astrocyte co-cultures, or cultured astrocytes (Edling et al., 2007;
Montes de Oca Balderas and Montes de Oca Balderas, 2018). However,
this effect is blocked by MK-801 or ifenprodil, but only in neuron /
astrocyte co-cultures. We have shown that MK-801 administration
suppresses PTZ-induced astrocyte activation, to the best of our knowl-
edge, for the first time. Astrocytes express the NMDA receptor
(Skowrońska et al., 2019). Dose-dependent astrocytes are affected by
the NMDA receptor-specific antagonist, MK-801 (Zhou et al., 2010).
The detailed mechanism by which MK-801 suppresses astrocyte acti-
vation remains to be elucidated. However, the well-known NMDA re-
ceptor channel blocker, memantine, has been reported to exert antic-
onvulsant effects during maximal electric shock attacks (Parsons et al.,
1995; Urbańska et al., 1992). There is evidence that another NMDA
receptor channel blocker, ketamine, is useful for treating refractory
status epilepticus (Dorandeu et al., 2013). MK-801 is suspected to have
the same mechanism as these drugs, but further studies are warranted
to investigate the mechanism by which PTZ-induced activation of as-
trocytes is suppressed. Although MK-801 acts as an anticonvulsant, it
can cause Olney’s lesions and induce cognitive impairment in experi-
mental rats (Coan et al., 1987; Murray et al., 1995, 1997). Therefore,
even if the antiepileptic effect of MK-801 is established, it cannot be
used clinically. This study suggests that chemicals with a similar me-
chanism of action as MK-801 have new therapeutic potential against
epilepsy.
In PTZ provocation tests, prior administration of α-pinene sig-
nificantly suppressed astrocyte activation in the hippocampus. Previous
studies have shown that α-pinene protects astrocytes from hydrogen
peroxide-induced oxidative stress cellular damage (Porres-Martínez
et al., 2015). Furthermore, monoterpenes such as α-pinene, citronellal,
citronellol, and myrcene antagonize NMDA receptors (Guimarães et al.,
2013). The detailed mechanism of α-pinene acting on astrocytes re-
mains unknown, but it is possible that it may affect the astrocyte NMDA
receptor. Further studies are warranted to elucidate the underlying
mechanism.
PTZ administration increased the PV neuron density in the CA3
Fig. 5. Immunohistochemical analysis of the GFAP-positive astrocytes in the
different treated group mouse hippocampus.
Representative immunofluorescent images of GFAP-positive astrocytes (A–D)
and Iba-1-positive microglia (E–H) in the CA1 of control (A, E), PTZ-kindled (B,
F), PTZ-kindled MK-801-treated (C, G), and PTZ-kindled a-pinene treated mice
(D, H). Quantified the percentage of GFAP-positive area in the SO and SR of the
CA1 of the different treated group mouse (I). Data are presented as the
mean± SEM (n = 6 mice per group). The p values indicate two-way ANOVA
by Bonferroni t-test. *p<0.05 for comparison between different treated groups
in the same region. Scale bars: 50 μm in H (applies to A–H). Respective p values
are listed in Table 1.
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region. It remains unclear whether the number of PV-positive neurons
increased or if the GABAergic interneurons increased PV expression. In
the PV-positive neurons of the sensory cortex, the expression level of PV
proteins depends on sensory input (Caballero et al., 2013). The increase
of PV neuron density in the CA3 region, therefore, may be correlated
with the increase of PV protein expression.
In this study, MK-801 was shown to suppress the increase of WFA-
and Cat-315-positive PNNs, and other ECM molecules induced by PTZ.
We have previously shown that WFA- and Cat-315-positive PNNs in-
creased in the hippocampus after kindling acquisition (Ueno et al.,
2019a, 2019b), while other studies have shown that PNNs are formed in
a stimulus-dependent manner (Lensjø et al., 2017; Ueno et al., 2017a,
2017b). The increased formation of PNNs preserves the repetitively
stimulated pathways during PTZ administration. In fact, patients with
temporal lobe epilepsy have elevated levels of chondroitin sulfate
proteoglycan (CSPG), the main component of brain ECM (Perosa et al.,
2002; Peixoto-Santos et al., 2017). The extracellular space is recognized
as an important mediator of neuronal plasticity (Berardi et al., 2004).
During regeneration following a spinal cord injury, ECM molecules
suppress axonal extension (Gaudet and Popovich, 2014). Therefore, the
increase in expression of ECM molecules in extracellular spaces ob-
served in PTZ-kindling mice suggests a decrease in the hippocampal
synaptic plasticity.
Loss of ECM components and degradation and removal of the ECM
have been shown to inhibit kindling acquisition in an epilepsy mouse
model (Hoffmann et al., 2009; Bausch, 2006). Therefore, blocking the
increase in the numbers of ECM molecules may have an antiepileptic
effect. Drugs that target ECM synthesis and degradation have been
proven to be effective antiepileptic treatments (Dityatev, 2010).
In addition, astrocytes produce ECM molecules such as CSPG, and
aggrecan (Wiese et al., 2012; Johnson et al., 2015), and the adminis-
tration of MK-801 can block astrocyte activation and attenuate ECM
production. In this study, MK-801 administration attenuated the PTZ-
induced activation of astrocytes and ECM increase. However, blocking
astrocyte activation may not be a direct consequence of blocking ECM.
Indeed, it has been suggested that suppression of astrocyte activation by
MK-801 may lead to suppression of epileptogenesis. The primary
components of PNN are ECM hyaluronic acid, tenascin, and members of
Fig. 6. Distribution of VGLUT1-positive and
GAD67-positive puncta in the different treated
group mouse hippocampus.
Representative immunofluorescent images of
VGLUT1-positive puncta (A–D) and GAD67-1-
positive puncta (E–H) in the CA1 of control (A,
E), PTZ-kindled (B, F), PTZ-kindled MK-801-
treated (C, G), and PTZ-kindled a-pinene
treated mice (D, H). Quantified mean fluores-
cence intensity of VGLUT1-positive puncta (I)
and GAD67-positive puncta (J), excluding the
GAD67-positive neurons, in the SO and SR of
the CA1 of the different treated group mouse.
Data are presented as the mean±SEM (n = 6
mice per group). The p values indicate two-
way ANOVA by Bonferroni t-test. *p< 0.05 for
comparison between different treated groups
in the same region. Scale bars: 50 μm in H
(applies to A–H). Respective p values are listed
in Table 1.
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the lectican family of chondroitin sulfate proteoglycans, such as ag-
grecan, versican, brevican, and neurocan (Bandtlow and Zimmermann,
2000; Yamaguchi, 2000). Further research is warranted to investigate
ECM changes.
In this study, we show that the administration of α-pinene sup-
pressed the increase of WFA- and Cat-315-positive PNNs, and ECM
molecules just as well as MK-801 administration. In the CA3 region, α-
pinene suppressed the increase of PNN density by PTZ administration,
but did not completely suppress the increase of WFA-positive fluores-
cence intensity and Cat-315-positive fluorescence intensity. This sug-
gests that α-pinene suppressed PNN formation around new PV-positive
neurons but could not suppress the increased expression of ECM mo-
lecules in PNN. Although the detailed mechanism of the PTZ-induced
astrocyte activation and the attenuation of the PTZ-induced ECM in-
crease by α-pinene is unknown, the present study shows that the ad-
ministration of α-pinene may be effective in blocking the ECM increase
by PTZ.
Administration of MK-801 significantly reduced the increase in ex-
pression of PV protein by PTZ. The expression level of PV protein de-
pends on the input stimulus (Caballero et al., 2013). Furthermore, PNN-
covered neurons, have higher PV protein expression than PV neurons
not covered with PNNs (Yamada et al., 2015; Ueno et al., 2017a,
2017b). In this study, PTZ kindling acquisition led to an increase in the
number of PNNs. PTZ induces a state of increased neural excitation in
the hippocampus (Squires et al., 1984). Also, in the hippocampus, the
expression of PV protein may be increased by high excitability due to
status epilepticus. In the groups in which MK-801, or α-pinene were
administered, the increase in PNN formation by PTZ was attenuated.
This suggests that MK-801 and α-pinene reduced the PTZ-induced PV
protein expression.
However, MK-801 and α-pinene treatments were unable to com-
pletely block the increase of VGLUT1 by PTZ. MK-801 reduced the in-
crease of VGLUT1 in the SO area of the CA1, but had no effect in the SR
area of the CA1. In animal models of epilepsy, an increase of VGLUT1 in
the hippocampus has been shown (Tannenberg and Dodd, 2009). An
increase in GAD67 was confirmed by the acquisition of PTZ kindling
which may suppress excessive neuronal excitation (Souchet et al.,
2015). A disturbance in the balance of inhibitory and excitatory neu-
rotransmitters is associated with epileptogenesis (Svenningsen et al.,
2006).
Currently, numerous antiepileptic drugs are available worldwide for
the treatment of epilepsy. Recent clinical and experimental evidence
suggests the association between epilepsy activity and microglial and
astrocyte activation and proliferation (Cohen-Gadol et al., 2004; de
Lanerolle et al., 2010). The present study shows that new therapeutic
agents targeting the inhibition of astrocyte activation and extracellular
matrix increase may be useful as antiepileptic drugs.
The results of this study show, albeit indirectly, an increase in
neural excitation in the hippocampus; however, MK-801 and α-pinene
treatments reduced kindling gain. These results indicate that promotion
of epileptogenesis by astrocytes and ECM molecules may be more
prominent for kindling acquisition than an increase in excitatory sy-
napses.
5. Conclusion
The results of this study show that in the PTZ kindling epilepsy
model, MK-801 and α-pinene attenuate status epilepticus. Furthermore,
MK-801 and α-pinene inhibited PTZ-induced astrocyte activation, in-
creased expression of PV protein, and increased ECM molecules. These
results indicate that astrocyte activation, and an increase in ECM, are
associated with an increase in seizures incidences.
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